Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA previously listed study location was updated and a new facility entry (“Northwest Cancer Center - Crown Point”) is now shown with a later update date. The page also reflects a revision/version change from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check19 days agoChange DetectedPage revision updated from v3.5.0 (2026-04-08) to v3.5.2 (2026-04-13).SummaryDifference0.0%

- Check26 days agoChange DetectedAdded update dates 2026-04-08 and 2026-04-09; removed 2026-04-02 and 2026-04-03.SummaryDifference0.0%

- Check33 days agoChange DetectedUpdated the Study Record Dates with new entries for 2026-04-02 and 2026-04-03, and removed older dates 2026-03-27, 2026-03-26, and 2025-09.SummaryDifference0.0%

- Check41 days agoChange Detected- Updated the page with new update dates (2026-03-27, 2026-03-26) and removed older dates (2026-03-20, 2026-03-19).SummaryDifference0.0%

- Check48 days agoChange DetectedAdded log entries for 2026-03-19 and 2026-03-20 and updated to Revision: v3.5.0. Deleted log entries for 2026-03-12 and 2026-03-13 and updated to Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.